Keywords: Tiotropium; Pulmonary resection; Pulmonary function; Antimuscarinic bronchodilator;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Bronchial asthma; Current smoker; Tiotropium;
Keywords: Asthma; House dust mite; Airway inflammation; Remodeling; Tiotropium; HDM; house dust mite; OVA; ovalbumin; BAL; bronchoalveolar lavage; LABA; long-acting β-2 adrenoceptor agonist; Tiotropium bromide (PubChem CID: 5487426); Olodaterol (PubChem CID: 11711
Keywords: Drug development; Drug delivery; Adherence; Inhaled corticosteroids; Long-acting β-agonists; Tiotropium; Biologics; Omalizumab;
Keywords: Tiotropium; COPD; Asthma; Respimat®; Lung function; Exacerbations; INSPIRE; Investigating New Standards for Prophylaxis in Reduction of Exacerbations; POET-COPD®; Prevention of Exacerbations with Tiotropium in COPD; TIOSPIR®; TIOtropium Safety and Perf
Keywords: Tiotropium; Aclidinium; The cough reflex; Long-acting muscarinic receptor antagonists; ASICs; Airway mechanoreceptorsASICs, acid-sensing ion channels; COPD, chronic obstructive pulmonary disease; DMSO, dimethyl sulfoxide; LAMAs, long-acting muscarinic rec
Keywords: Chronic obstructive pulmonary disease (COPD); Clinical trials; Health-related quality of life; Responder and deteriorator rates; St George's Respiratory Questionnaire (SGRQ); Tiotropium; COPD; chronic obstructive pulmonary disease; EXACTT; Exercise Endura
Keywords: Asthma; Early asthma; Inhaled corticosteroids; Lebrikizumab; Mepolizumab; Omalizumab; Severe asthma; Tiotropium;
Keywords: budesonide; doxofylline; formoterol; montelukast; tiotropium;
Keywords: Asthma; tiotropium; salmeterol; responder analysis; predictor of response; ACD; Asthma control day; ACRN; Asthma Clinical Research Network; FVC; Forced vital capacity; HFA; Hydrofluoroalkane; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LAMA
Keywords: Airway remodeling; asthma; asthma control; asthma exacerbations; asthma impairment; asthma risk; asthma severity; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting β-ad
Keywords: Mucus hypersecretion; COPD; Tiotropium; CASA-Q; Mucociliary clearance
Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA
Keywords: Combination therapy; COPD; Inhaled corticosteroids; Long-acting bronchodilators; LAMA/LABA; Fixed-dose dual bronchodilators; CDS; Chronic Disease Score; CI; confidence interval; COPD; chronic obstructive pulmonary disease; ER; emergency room; FDC; fixed-d
Tiotropium inhibits mucin production stimulated by neutrophil elastase but not by IL-13
Keywords: Tiotropium; Mucus; Neutrophil elastase; IL-13; Bronchial epithelial cell;
Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus
Keywords: Human M3 muscarinic receptor; Long-acting anticholinergic; Human bronchus; Tiotropium;
M3-subtype muscarinic receptor activation stimulates intracellular calcium oscillations and aldosterone production in human adrenocortical HAC15 cells
Keywords: Fluo-4; CHRM3; CHRM2; Hypertension; Tiotropium; Methoctramine;
Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
Keywords: Tiotropium; Long-acting muscarinic antagonist; Long-acting β2-agonist; Inhaled corticosteroids; Asthma; ACRN; Asthma Clinical Research Network; AE; adverse event; B16-Arg/Arg; arginine single nucleotide polymorphism at amino acid 16 in the β2-adrenergic
Tiotropium Attenuates Refractory Cough and Capsaicin Cough Reflex Sensitivity in Patients with Asthma
Keywords: Chronic asthmatic cough; Capsaicin cough reflex sensitivity; Tiotropium; Cough severity; Cough-specific quality of life; ACT; Asthma Control Test; ICS; Inhaled corticosteroids; J-LCQ; Japanese version of Leicester Cough Questionnaire; LABA; Long-acting β
Effect of a single exacerbation on decline in lung function in COPD
Keywords: PFT; Pulmonary function test; UPLIFT®; Understanding Potential Long-term Impacts on Function with Tiotropium; Bronchodilator; COPD; Exacerbation; Lung function decline; Tiotropium;
Pharmacokinetics of tiotropium administered by Respimat® in asthma patients: Analysis of pooled data from Phase II and III clinical trials
Keywords: Tiotropium; Pharmacokinetics; Asthma; Respimat® inhaler;
Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial
Keywords: Chronic obstructive pulmonary disease; Glycopyrronium; Tiotropium; Airway resistance; Fast onset; Body plethysmography;
Long-term safety and efficacy of combined tiotropium and olodaterol in Japanese patients with chronic obstructive pulmonary disease
Keywords: AE; adverse event; AUC0-3; area under the curve from 0 to 3Â h; COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in 1Â s; FVC; forced vital capacity; GOLD; Global initiative for chronic Obstructive Lung Disease; ICH-E1; Intern
Evaluation of COPD Treatments: A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States
Keywords: aclidinium; chronic obstructive pulmonary disease; multicriteria decision analysis; tiotropium;
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma
Keywords: Anticholinergic drug; asthma; asthma control; children; efficacy; FEV1; lung function; Respimat; safety; tiotropium; ACQ-IA; Interviewer-administered Asthma Control Questionnaire; FEF25-75; Forced expiratory flow at 25% to 75% of the forced vital capacity
Tiotropium add-on therapy in adolescents with moderate asthma: AÂ 1-year randomized controlled trial
Keywords: Adolescent; anticholinergic drug; asthma; asthma control; efficacy; FEV1; lung function; Respimat; safety; tiotropium; ACQ-6; 6-question Asthma Control Questionnaire; ACQ-7; 7-question Asthma Control Questionnaire; AQLQ(S)+12; Asthma Quality of Life Quest
Safety and tolerability of once-daily tiotropium Respimat® as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis
Keywords: Asthma; Respimat®; Safety; Tiotropium; Tolerability;
Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease
Keywords: Chronic obstructive pulmonary disease; Combination therapy; Forced oscillation technique; Indacaterol; Tiotropium;
Tiotropium Respimat® in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials
Keywords: Bronchodilator; Cystic fibrosis; Respimat; Tiotropium
The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease
Keywords: Chronic obstructive pulmonary disease; Combination therapy; Olodaterol; Tiotropium; AUC0-12; area under the curve from 0 to 12Â h; AUC0-24; area under the curve from 0 to 24Â h; AUC12-24; area under the curve from 12 to 24Â h; COPD; chronic obstruct
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life
Keywords: COPD; Quality of life; Long-acting bronchodilator; Tiotropium; Olodaterol; AE; adverse event; AUC0-3; area under the curve from 0 to 3Â h; COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in 1Â s; GOLD; Global initiative for c
Pulmonary, gastrointestinal and urogenital pharmacologyPharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi
Keywords: Aclidinium; Glycopyrronium; Tiotropium; COPD; Onset of action;
Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety model
Keywords: Muscarinic; COPD; Cardiovascular; Respiratory; Glycopyrronium; Tiotropium;
Indacaterol vs tiotropium in COPD patients classified as GOLD A and B
Keywords: Indacaterol; Tiotropium; COPD; GOLD; Efficacy;
Once-daily tiotropium Respimat® 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma
Keywords: Asthma; Tiotropium; Dosing regimen; Bronchodilator efficacy; Anticholinergic drug; Long-acting bronchodilator; ACQ-7; seven-question Asthma Control Questionnaire; AM2+®; Asthma Monitor2+ device; AUC; area under the curve; AUC(0-Ï),ss; area under the c
Characterization of V0162, a new long-acting antagonist at human M3 muscarinic acetylcholine receptors
Keywords: ACh; acetylcholine; COPD; chronic obstructive pulmonary disease; EFS; electrical field stimulation; hM3R; human muscarinic M3 acetylcholine receptor; KHS; Krebs-Henseleit solution; LABA; long-acting beta adrenergic agonist; LAMA; long-acting muscarinic
Benefits of adding fluticasone propionate/salmeterol to tiotropium in COPD: A meta-analysis
Keywords: Tiotropium; Fluticasone propionate/salmeterol; Efficacy; Safety; COPD; Meta-analysis
Bronchodilator efficacy of tiotropium–formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD
Keywords: Tiotropium; Formoterol; COPD
Pooled analysis of tiotropium Respimat® pharmacokinetics in cystic fibrosis
Keywords: Tiotropium; Respimat® inhaler; Pharmacokinetics; Cystic fibrosis;
Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study
Keywords: Chronic obstructive pulmonary disease; QVA149; Exercise; Hyperinflation; Tiotropium;
Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: A randomised dose-ranging study
Keywords: Tiotropium; Anticholinergic; Bronchodilator; Asthma; Adolescents; Inhaled corticosteroids;
Efficacy and safety of umeclidinium/vilanterol 62.5/25Â mcg and tiotropium 18Â mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial
Keywords: Long-acting bronchodilator; Umeclidinium; Vilanterol; AE; adverse event; CI; confidence interval; COPD; chronic obstructive pulmonary disease; DPI; Dry powder inhaler; FEV1; forced expiratory volume in one second; FP; fluticasone propionate; FVC; forced v
Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients
Keywords: Glycopyrronium; Indacaterol; Pooled analysis; QVA149; Safety; Tiotropium;
Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD
Keywords: AZD9164; COPD; FEV1; Muscarinic antagonist; Tiotropium; Bronchodilator;
Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®)
Keywords: Forced expiratory volume; Forced vital capacity; Placebo-controlled; Tiotropium;
Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients
Keywords: COPD; Tiotropium; Salmeterol; Exacerbations; GOLD stage II; Maintenance therapy;
Comparative Effectiveness of Tiotropium and Ipratropium in Prevention of Hospital Readmission for COPD: A Population-Based Cohort Study
Keywords: COPD; hospital admission; ipratropium; tiotropium;
A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium
Keywords: Tiotropium; COPD; Exacerbation; Hospitalization; Cardiac;
Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries
Keywords: Budesonide/formoterol; Tiotropium; Cost effectiveness; Nordic; COPD;
Keywords: COPD; health care; respiratory disease; tiotropium; utilization
Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes
Keywords: Bronchial asthma; Chronic obstructive pulmonary disease; Tiotropium